The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells

Blood

Volumn 90, Issue 3, 1997, Pages 1091-1100

  Cantin, Réjean ^b   Fortin, Jean François ^b   Lamontagne, Ginette ^b   Tremblay, Michel ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CONTROLLED STUDY; HELA CELL; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS REPLICATION;

EID: 0030844666     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1091.1091_1091_1100     Document Type: Article

References (79)

1. Somasundaran M, Robinson HL: A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J Virol 61:3114, 1987
2. Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A: Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: Mechanism for persistence in AIDS. Cell 53:483, 1988
3. Hunter E: Macromolecular interactions in the assembly of HIV and other retroviruses. Semin Virol 5:71, 1994
4. Henderson LE, Sowder R, Copeland TD, Oroszlan S, Arthur LO, Robey WG, Fischinger PJ: Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol 61:629, 1987
5. Hoxie J, Fitzharris TP, Yougbar PR, Matthews DM, Rackowski JL, Radka SF: Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol 18:39, 1987
6. Schols D, Pauwels R, Desmyter J, De Clerk E: Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology 189:374, 1992
7. Arthur LO, Bess JWJ, Sowder II RC, Benveniste RE, Mann DL, Cherman J-C, Henderson LE: Cellular proteins bound to immunodeficiency viruses: Implication for pathogenesis and vaccines. Science 258:1935, 1992
8. Orentas RJ, Hildreth JEK: Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 9:1157, 1993
9. Capobianchi MR, Fais S, Castilletti C, Gentile M, Ameglio F, Dianzani F: A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J Infect Dis 169:886, 1994
10. Saifuddin M, Parker CJ, Peeples ME, Gorny MK, Zolla-Pazner S, Ghassemi M, Rooney IA, Atkinson JP, Spear GT: Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 182:501, 1995
11. Benkirane M, Blanc-Zouaoui D, Hirn M, Deveaux C: Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells. J Virol 68:6332, 1994
12. Castilletti C, Capobianchi MR, Fais S, Abbate I, Ficociello B, Ameglio F, Cordiali Fei P, Santini SM, Dianzani F: HIV type 1 grown on Interferon γ-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res Hum Retroviruses 11:547, 1995
13. Fais S, Capobianchi MR, Abbate I, Catilletti C, Gentile M, Cordiali Fei P, Ameglio F, Dianzani F: Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with copolarization of intercellular adhesion molecules (ICAM-1) and HIV-1 viral matrix protein. AIDS 9:329, 1995
14. Gelderblom H, Reupke H, Winkel T, Kunze R, Pauli G: MHC-antigens: Constituents of the envelopes of human and simian immunodeficiency viruses. Z Naturforsch 42:1328, 1987
15. Merloo TH, Parmentier HK, Osterhaus ADME, Goudsmit J. Schuurman H-J: Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS 6:1105, 1992
16. Merloo T, Sheikh MA, Bloem AC, de Ronde A, Schutten M, van Els CAC, Roholl PJM, Joling P, Goudsmit J, Schuurman H-J: Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. J Gen Virol 74:129, 1993
17. Dalgleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763, 1984
18. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767, 1984
19. Doyle C, Strominger J: Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256, 1987
20. Eichmann K, Jonsson J, Falk I, Emmrich F: Effective activation of resting mouse T lymphocyte by crosslinking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur J Immunol 17:643, 1987
21. Emmrich F, Kantz L, Eichmann K: Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells. Eur J Immunol 17:529, 1987
22. Julius M, Newell K, Maroun C, Haughn L: Functional consequences of CD4-TCR/CD3 interactions. Semin Immunol 3:161, 1991
23. Kupfer A, Singer SJ, Janeway CA, Swain SL: Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells. Proc Natl Acad Sci USA 84:5888, 1987
24. Ledbetter JA, June CH, Grosmaire LS, Rabinovitch PS: Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in lymphocytes. Proc Natl Acad Sci USA 84:1384, 1987
25. Ledbetter JA, Gilliland LK, Schieven GL: The interaction of CD4 with CD3/Ti regulates phosphorylation of substrates during T cell activation. Semin Immunol 2:99, 1990
26. Nepom BS, Nepom GT: Immunogenetics and the rheumatic disease, in Kelly WN, Harris EDJ, Ruddy S, Sledge CB (eds): Textbook of Rheumatology. Philadelphia, PA, Saunders, 1993, p 89
27. Lee JS: Regulation of HLA class II gene expression, in Dupont B (ed): Immunobiology of HLA. New York, NY, Springer-Verlag, 1987, p 49
28. Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG: Peripheral blood Ia positive T cells increased in certain diseases after immunisation. J Exp Med 151:91, 1980
29. Ko HS, Fu SM, Winchester RJ, Yu DTY, Kunkel HG: Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen and antigen activated T cells. J Exp Med 150:246, 1979
30. Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF: Ia determinants on human T cell subsets defined by monoclonal antibodies. Activation stimuli required for expression. J Exp Med 150:1472, 1979
31. Fenouillet E, Clerget-Raslain B, Gluckman JC, Guetard D, Montagnier L, Bahraoui E: Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its cellular CD4 receptor. J Exp Med 169:807, 1989
32. Gelderblom HR, Hausmann EHS, Özel M, Pauli G, Koch MA: Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171, 1987
33. Gelderblom HR, Reupke H, Pauli G: Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet 11:1016, 1985
34. Kimpton J, Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 66:2232, 1992
35. Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, Yamamoto N: Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol 57:1159, 1986
36. Smith SD, Shatsky, Cohen MPS, Warnke R, Link MP, Glader BE: Monoclonal antibody and enzymatic profiles of human malignant T lymphoid cells and derived cell lines. Cancer Res 44:5657, 1984
37. Willard-Gallo KE, Van de Keere F, Kettmann R: A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci USA 87:6713, 1990
38. Accolla RS: Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J Exp Med 157:1053, 1983
39. Calman A, Peterlin MB: Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J Immunol 139:2489, 1987
40. Tremblay M, Meloche S, Gratton S, Wainberg MA, Sékaly RP: Association of p561ck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 13:774, 1994
41. Sleckman BP, Peterson A, Jones WK, Foran JA, Greenstein JL, Seed B, Burakoff SJ: Expression and function of CD4 in a murine T-cell hybridoma. Nature 328:351, 1987
42. Peterson A, Seed B: Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54:65, 1988
43. Lampson LA, Levy R: Two populations of la-like molecule on a human B cell line. J Immunol 125:293, 1980
44. Charron DJ, McDevitt HO: Analysis of HLA-D region-associated with monoclonal antibody. Proc Natl Acad Sci USA 76:6567, 1979
45. Van Wauwe JP, de Mey JR, Goossens JG: OKT3: A monoclonal anti-human T lymphocyte antibody with mitogenic properties. J Immunol 124:2708, 1980
46. Brodsky FM, Parham P: Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 128:129, 1982
47. Watson JA, De Mars R, Trowbridge IS, Bach FH: Detection of a novel human class II HLA antigen. Nature 304:358, 1983
48. Accolla RS, Sékaly R-P, McDonald AP, Corte G, Gross N, Carrel S: Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets. Eur J Immunol 12:166, 1982
49. Harada S, Koyanagi Y, Yamamoto N: Infection of HTLV-III/LAV in HTLV-1 carrying MT-2 and MT-4 and application in a plaque assay. Science 229:563, 1985
50. Tremblay M, Meloche S, Sékaly R-P, Wainberg MA: Complement receptor type 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells. J Exp Med 171:1791, 1990
51. Reed LJ, Muench HA: A simple method of estimating fifty percent endpoints. Am J Hyg 27:493, 1938
52. Cantin R, Fortin J-F, Tremblay M: The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 218:372, 1996
53. Bernier R, Tremblay M: Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J Virol 69:291, 1995
54. Fernie BF, Poli G, Fauci AS: Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphotropic cells. J Virol 65:3968, 1991
55. Kalyanaraman VS, Pal R, Galo RC, Sarngadharan MG: A unique human immunodeficiency virus culture secreting soluble gp160. AIDS Res Hum Retroviruses 4:319, 1988
56. Kirsh R, Hart TK, Ellens H, Miller J, Petteway SAJ, Lambert DM, Leary J, Bugelski PJ: Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1. AIDS Res Hum Retroviruses 6:1209, 1990
57. Laurent AG, Krust B, Rey A-M, Montagnier L, Hovanessian AG: Cell surface expression of several species of human immunodeficiency virus type 1 major core protein. J Virol 63:4074, 1989
58. Kinch MS, Strominger JL, Doyle C: Cell adhesion mediated by CD4 and MHC class II proteins requires active cellular processes. J Immunol 9:4552, 1993
59. McKeating JA, McKnight A, Moore JP: Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralization. J Virol 65:852, 1991
60. Layne SP, Merges MJ, Dembo M, Spouge JL, Nara PL: HIV requires multiple gp120 molecules for CD4-mediated infection. Nature 346:277, 1990
61. Blanchard D, Van Els C, Aubry JE, De Vries JE, Spits H: CD4 is involved in a post-binding event in the cytolytic reaction by human CD4+ cytotoxic T lymphocytes clones. J Immunol 140:1745, 1988
62. Gay DP, Maddon PJ, Sékaly R-P, Talle A, Godfrey M, Long E, Goldstein G, Chess L, Axel R, Kappler J, Marrack P: Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 328:626, 1987
63. Cammarota G, Scheirle A, Takacs B, Doran DM, Knorr R, Bannwarth W, Guardiola J, Sinigaglia F: Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature 356:799, 1992
64. Fernandez-Larsson R, Srivastava KK, Lu S, Robinson HL: Replication of patient isolates of human immunodeficiency virus type 1 in T cells: A spectrum of rates and efficiency of entry. Proc Natl Acad Sci USA 89:2223, 1992
65. Gomez MB, Hildreth JEK: Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1. J Virol 69:4628, 1995
66. Saifuddin M, Ghassemi M, Patki C, Parker CJ, Spear GT: Host cell components affect the sensivity of HIV type 1 to complement-mediated virolysis. AIDS Res Hum Retroviruses 10:829, 1994
67. Guo MML, Hildreth JEK: HIV acquires functional adhesion receptors from host cells. AIDS Res Hum Retroviruses 11:1007, 1995
68. Rossio JL, Bess J, Henderson LE, Cresswell P, Arthur LO: HLA class II on HIV particles is functional in superantigen presentation to human T cells: Implications for HIV pathogenesis. AIDS Res Hum Retroviruses 11:1433, 1995
69. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305, 1989
70. Popovic M, Gartner S: Isolation of HIV-1 from monocytes but not T lymphocytes. Lancet 2:916, 1987
71. Zambruno G, Giannetti A, Bertzzoni U, Girolomoni G: Langerhans cells and HIV infection. Immunol Today 16:520, 1995
72. Frankel SS, Wenig BM, Burke AP, Mannam P, Thompson LDR, Abbondanzo SL, Nelson AM, Pope M, Steinman RM: Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115, 1996
73. Hsia K, Tsai V, Zvaifler NJ, Spector SA: Low prevalence of HIV-1 proviral DNA in peripheral blood monocytes and dendritic-cells from HIV-1-infected individuals. AIDS 9:398, 1995
74. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
75. Freudenthal PS, Steinman RM: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87:7698, 1990
76. Gelderblom HR: Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS 5:617, 1991
77. Fleury S, Thibodeau J, Croteau G, Labrecque N, Aronson H-E, Cantin C, Long EO, Sékaly R-P: HLA-DR polymorphism affects the interaction with CD4. J Exp Med 182:733, 1995
78. Chan WL, Rodgers A, Grief C, Almond N, Ellis S, Flanagan B, Silvera P, Bootman J, Stott J, Kent K, Bomford R: Immunization with class I histocompatibility leukocyte antigen can protect macaques against challenge infection with SIV mac-32H. AIDS 9:223, 1995
79. Arthur LO, Bess JWJ, Urban RG, Strominger JL, Morton WR, Mann DL, Henderson LE, Benveniste RE: Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 69:3117, 1995